[Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease]. [PDF]
Fatty Liver and Alcoholic Liver Disease Study Group +2 more
europepmc +1 more source
[Research progress on the mechanism of mitochondrial dynamics in diabetic foot ulcers and its related intervention strategies]. [PDF]
Shan B +6 more
europepmc +1 more source
[Oral-Systemic Antiaging Mechanisms and Intervention Strategies Guided by Traditional Chinese Medicine Principle of Preventive Treatment of Disease]. [PDF]
Ai H, Li C, Jin Z, Zuo Y.
europepmc +1 more source
[White matter microstructural disturbance and its relationship with cognitive function in schizophrenia with comorbidity of metabolic syndrome]. [PDF]
Zhou J +7 more
europepmc +1 more source
[Noninvasive scores for predicting liver-related events in patients with metabolic dysfunction-associated fatty liver disease]. [PDF]
Gao YK +6 more
europepmc +1 more source
[Multiple clinical effects of recombinant human growth hormone therapy]. [PDF]
Zhou B, Yang Y.
europepmc +1 more source
[Precise clinical classification of metabolic associated fatty liver disease]. [PDF]
Su WR, Ding JJ, Pan Q, Chai J.
europepmc +1 more source
[<i>Qihuang Jianpi Zishen</i> Granule ameliorates renal injury in patients with systemic lupus erythematosus by regulating immunometabolic reprogramming of macrophages]. [PDF]
Qian A +5 more
europepmc +1 more source
[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease]. [PDF]
Wu ST, Lu XL.
europepmc +1 more source
[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease]. [PDF]
Wang XY, Sun HM, Gao YH.
europepmc +1 more source

